


Ask a doctor about a prescription for BRONCHITOL 40 mg INHALATION POWDER, HARD CAPSULES
PACKAGE LEAFLET: INFORMATION FOR THE USER
Bronchitol 40 mg powder for inhalation, hard capsules
Mannitol
Read all of this leaflet carefully before you start using this medicine because it contains important information for you.
Contents of the pack
What is Bronchitol
Bronchitol contains a medicine called mannitol, which is a mucolytic.
What is Bronchitol used for
Bronchitol is used in adults aged 18 years and older. In addition to using Bronchitol, the patient will continue to take their usual medication for cystic fibrosis.
How Bronchitol works
Bronchitol is inhaled into the lungs to improve cystic fibrosis, a genetic disease that affects the glands in the lungs, intestines, and pancreas that secrete fluids such as mucus and digestive juices.
Bronchitol helps to increase the amount of water present on the surface of the airways and in the mucus. This allows the lungs to clear the mucus more easily. It also helps to improve the condition of the lungs and breathing. As a result, a "productive cough" may occur, which also helps to clear the mucus from the lungs.
Do not use Bronchitol
If any of the above applies to you (or if you are not sure), talk to your doctor or pharmacist before using this medicine.
Warnings and precautions
Talk to your doctor or pharmacist before using this medicine.
Inhaling medicines can cause chest tightness and wheezing, in some cases immediately after taking the medicine. Your doctor will help you take your first dose of Bronchitol and check your lung function before, during, and after administration. Your doctor may ask you to use other medicines such as a bronchodilator before taking Bronchitol.
Inhaling medicines can also cause coughing, this may happen with Bronchitol. Talk to your doctor if the cough does not go away or worries you.
Children and adolescents
Bronchitol should not be used in children and adolescents under 18 years of age. This recommendation is due to the limited information available in this patient group.
Using Bronchitol with other medicines
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.
You can continue to take your cystic fibrosis medicines when using Bronchitol, these include inhaled antibiotics such as tobramycin and colistimethate sodium. If you are unsure, talk to your doctor or pharmacist before taking Bronchitol.
Pregnancy and breastfeeding
Driving and using machines
Bronchitol is unlikely to affect your ability to drive or use tools or machines.
Follow the instructions for administration of this medicine exactly as your doctor has told you. If you are not sure, talk to your doctor or pharmacist.
Always use your bronchodilator before using Bronchitol.
Recommended dose
Adults aged 18 years and older
Initial dose
Before your doctor prescribes Bronchitol, they will help you take your first dose of Bronchitol and perform a lung function test at each step to check that you are not sensitive to mannitol. The first dose is taken in four steps:
Step 1 - 1 capsule (40 mg)
Step 2 - 2 capsules (80 mg)
Step 3 - 3 capsules (120 mg)
Step 4 - 4 capsules (160 mg)
At the end of the initial dose, you will have taken 10 capsules (400 mg), which is the normal dose.
Treatment dose (2-week packs)
Order for using this medicine
Use Bronchitol as part of your normal daily treatment routine. The suggested order is as follows, unless otherwise directed by your doctor:
How to use Bronchitol
For instructions on using the inhaler, see the end of the leaflet.
If you use more Bronchitol than you should
If you think you have taken too much of this medicine, talk to your doctor or pharmacist immediately. You may:
Your doctor will give you oxygen and medicine to help you breathe.
If you forget to use Bronchitol
If you stop using Bronchitol
If you stop using Bronchitol, your symptoms may get worse. Do not stop using Bronchitol without talking to your doctor first, even if you feel better. Your doctor will tell you how long you should use this medicine.
If you have any further questions on the use of this product, ask your doctor or pharmacist.
Like all medicines, Bronchitol can cause side effects, although not everybody gets them.
Stop using Bronchitol and talk to a doctor immediately if you notice any of the following serious side effects:
Tell your doctor immediately if you notice any of the following side effects:
Other side effects are:
Common (may affect up to 1 in 10 people)
Uncommon (may affect up to 1 in 100 people)
Reporting of side effects
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system listed in Appendix V*. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep out of the sight and reach of children.
Do not use Bronchitol after the expiry date which is stated on the carton and blister after 'EXP'. The expiry date is the last day of the month stated.
Store below 30°C.
Store in the original package to protect from moisture.
Once removed from the blister, the capsule should be used immediately.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
Bronchitol Composition
The active ingredient is mannitol. Each capsule contains 40 mg of mannitol. The average inhaled dose per capsule is 32.2 milligrams of mannitol.
Product Appearance and Package Contents
Bronchitol is a powder for inhalation in hard capsules. Bronchitol 40 mg powder for inhalation, hard capsules, is a white or almost white powder in hard, transparent, and colorless capsules with the inscription «PXS 40 mg». The powder is inhaled into the lungs with the inhaler provided in the package.
Each initial dose package of Bronchitol contains 1 blister pack with 10 capsules and 1 inhaler. The initial dose package is used for the initial dose evaluation with your doctor.
Each 2-week treatment package of Bronchitol contains 28 blister packs with 10 capsules each (280 capsules in total) and 2 inhalers. The 2-week treatment package is for therapeutic use.
Marketing Authorization Holder and Manufacturer
Pharmaxis Europe Limited, 108 Q House, Furze Road, Sandyford, Dublin 18, D18AY29, Ireland
Manufacturer
MIAS Pharma Limited, Suite 1, Stafford House, Strand Road, Portmarnock, Co. Dublin, D13WC83, Ireland or Arvato Supply Chain Solutions SE, Gottlieb-Daimler Straβe 1, 33428 Harsewinkel, North Rhine-Westphalia, Germany.
You can request more information about this medication by contacting the local representative of the marketing authorization holder:
Belgium Pharmaxis Europe Limited Tel: + 353 (0) 1431 9816 | Lithuania Pharmaxis Europe Limited Tel: + 353 (0) 1431 9816 |
Greece Pharmaxis Europe Limited Tel: + 353 (0) 1431 9816 | Luxembourg Pharmaxis Europe Limited Tel: + 353 (0) 1431 9816 |
Czech Republic 4 Life Pharma CZ, s.r.o. Tel: +420 244 403 003 | Hungary Pharmaxis Europe Limited Tel: + 353 (0) 1431 9816 |
Denmark Chiesi Pharma AB Tel: + 46 8 753 35 20 | Malta Pharmaxis Europe Limited Tel: + 353 (0) 1431 9816 |
Germany Chiesi GmbH Tel: +49 (0) 40 897 240 | Netherlands Pharmaxis Europe Limited Tel: + 353 (0) 1431 9816 |
Estonia Pharmaxis Europe Limited Tel: + 353 (0) 1431 9816 | Norway Chiesi Pharma AB Tel: + 46 8 753 35 20 |
Greece Chiesi Hellas A.E.B.E. Tel: + 30.210.617.97.63 | Austria Pharmaxis Europe Limited Tel: + 353 (0) 1431 9816 |
Spain Chiesi España, S.A.U. Tel: +34 93 494 8000 | Poland IMED Poland Sp. z o. o. Tel: +48 22 663 43 10 |
France Pharmaxis Europe Limited Tel: + 353 (0) 1431 9816 | Portugal Pharmaxis Europe Limited Tel: + 353 (0) 1431 9816 |
Croatia Pharmaxis Europe Limited Tel: + 353 (0) 1431 9816 | Romania Pharmaxis Europe Limited Tel: + 353 (0) 1431 9816 |
Ireland Cheisi Limited Tel: + 44 (0)161 488 5555 | Slovenia Pharmaxis Europe Limited Tel: + 353 (0) 1431 9816 |
Iceland Pharmaxis Europe Limited Tel: + 353 (0) 1431 9816 | Slovakia 4 Life Pharma SK, s.r.o. Tel: + 420 244 403 003 |
Italy Chiesi Farmaceutici S.p.A Tel: +39 0521 2791 | Finland Chiesi Pharma AB Tel: + 46 8 753 35 20 |
Cyprus Chiesi Hellas A.E.B.E. Tel: + 30.210.617.97.63 | Sweden Chiesi Pharma AB Tel: + 46 8 753 35 20 |
Latvia Pharmaxis Europe Limited Tel: + 353 (0) 1431 9816 | United Kingdom Cheisi Limited Tel: + 44 (0)161 488 5555 |
Date of the Last Revision of this Prospectus: MM/YYYY.
Other Sources of Information
Detailed information about this medication is available on the European Medicines Agency website: http://www.ema.europa.eu. There are also links to other websites about rare diseases and orphan medicines.
------------------------------------------------------------------------------------------------------------------>
How to Use the Inhaler
The following diagram explains how the inhaler works. Bronchitol capsules can only be used with the inhaler provided in the package.

Spinning Chamber: Spiral Chamber
Mouthpiece: Mouthpiece
Filter: Filter
Piercing Buttons: Piercing Buttons
Piercing Chamber: Piercing Chamber
Inhaler
The following steps explain how to use the inhaler. If you want more information on how to care for it, go to the end of the instructions.
|
|
|
|
|
|
|
|
| |
|
|
| |
|
|
|
|
| |
|
Additional Information on Inhaler Care
Cleaning the Inhaler -Normally, the inhaler will deliver the correct dose of medication for 7 days without needing cleaning. If you need to clean it, follow these steps:
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for BRONCHITOL 40 mg INHALATION POWDER, HARD CAPSULES – subject to medical assessment and local rules.